NCT02223286View on ClinicalTrials.gov

Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making

CompletedOBSERVATIONAL
Enrollment

552

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

August 31, 2014

Conditions
Coronary Artery DiseaseAngina PectorisChest PainCardiovascular DiseasesCoronary Heart DiseaseCADCVDCHD
Interventions
DIAGNOSTIC_TEST

Corus CAD

Age/Sex/Gene Expression Score

Trial Locations (3)

30513

Piedmont Heart Institute, Blue Ridge

44504

Heart Associates, Youngstown

85037

John C. Lincoln Heart Institute, Phoenix

Sponsors

Lead Sponsor

CardioDx
All Listed Sponsors
lead

CardioDx

INDUSTRY

NCT02223286 - Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making | Biotech Hunter | Biotech Hunter